Roivant Sciences Ltd. (ROIV)
Health Care ยท Pharmaceutical Preparations
Roivant Sciences Ltd. (ROIV) is listed on Nasdaq, where its shares have traded since October 1, 2021. SentiSense covers Roivant Sciences Ltd. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Matt Gline is its chief executive officer. The company reports 721 employees, and its corporate website is www.roivant.com.
About Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Latest reported results
Roivant Sciences Ltd. reported revenue of $1.4 million for Q1 FY2026, down 33.5% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 487 institutions reported holding ROIV, with 554.3 million shares worth $19.6 billion in aggregate. The largest reported holders were FMR, BlackRock and Vanguard. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on ROIV
- ROIV sentiment: whether news and social coverage of Roivant Sciences Ltd. leans bullish or bearish, and the stories driving it.
- ROIV ownership: all 487 reporting institutions, plus insider and congressional trades.
- ROIV financials: revenue, net income, operating margin and free cash flow through Q1 FY2026.
SentiSense also tracks daily options readings for Roivant Sciences Ltd.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Roivant Sciences Ltd. do?
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
What sector is ROIV in?
SentiSense classifies Roivant Sciences Ltd. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ROIV stock trade?
Roivant Sciences Ltd. (ROIV) is listed on Nasdaq, where its shares have traded since October 1, 2021.
Who is the CEO of Roivant Sciences Ltd.?
Matt Gline is the chief executive officer of Roivant Sciences Ltd..